作者: Johnny Y. Nagasawa , Nicholas D. Smith , Daniel Fred Ortwine , Jun Liang , Jason Zbieg
DOI:
关键词:
摘要: Described herein are compounds that estrogen receptor modulators of Formula I and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, with the substituents structural features described herein. Also pharmaceutical compositions medicaments include herein, as well methods using such modulators, alone in combination other compounds, for treating diseases conditions mediated dependent upon receptors.